Potential of human serum albumin as chiral selector of basic drugs in affinity electrokinetic chromatography‐partial filling technique

Electrophoresis - Tập 27 Số 21 - Trang 4364-4374 - 2006
María Amparo Martínez‐Gómez1, R.M. Villanueva-Camañas1, S. Sagrado1, M.J. Medina-Hernández1
1University of Valencia, Departamento de Química Analítica, Facultat de Farmacia, Universitat de Valencia, Burjassot, Valencia, Spain

Tóm tắt

AbstractThe enantiomeric resolution of compounds using HSA by means of affinity EKC (AEKC)‐partial filling technique is the result of a delicate balance between different experimental variables such as protein concentration, running pH (background electrophoretic buffer (BGE), protein, and compound solutions), and plug length. In this paper, the possibility of using HSA as chiral selector for enantioseparation of 28 basic drugs using this methodology is studied. The effect of the physicochemical parameters, the structural properties of compounds, and compound–HSA protein binding percentages over their chiral resolution with HSA is outlined. Based on the results obtained, a decision tree is proposed for the “a priori” prediction of the capability of HSA for enantioseparation of basic drugs in AEKC. The results obtained indicated that enantioresolution of basic compounds with HSA depends on the hydrophobicity, polarity, and molar volume of compounds.

Từ khóa


Tài liệu tham khảo

10.1016/S0376-7388(00)00370-7

González‐Alonso I., 1998, Biofarmacia y Farmacocinética, 467

Evans W. E., 1992, Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring

10.1016/S0065-3233(08)60640-3

Peters T., 1996, All About Albumin, Genetics and Medical Applications, 1

10.1126/science.2727704

10.1016/S0021-9673(99)01168-1

10.1016/j.jchromb.2003.08.035

10.1016/0021-9673(94)00790-G

10.1016/S0165-022X(01)00143-9

10.1016/0021-9673(93)83437-W

10.1002/elps.1150190223

Martínez J. J., 2004, J. Chromatogr. A, 1048, 111

10.1016/j.aca.2003.11.029

10.1016/S0021-9673(00)00532-X

10.1002/elps.200500304

Hansch C., 1990, Comprehensive Medicinal Chemistry

10.1021/ac970464o

10.1016/S1570-0232(03)00606-8

10.1002/1522-2683(200203)23:6<951::AID-ELPS951>3.0.CO;2-R

10.1002/elps.200406049

10.1002/elps.200600102

10.1016/j.jpba.2005.03.028

10.1021/jm000942e